COMMUNIQUÉS West-GlobeNewswire

Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued Listing
08/10/2026
Company remains focused on its transition toward commercial revenue generation and the advancement of its U.S. clinical programs HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “ [...]
Retrieve Medical Announces National Distribution Agreement for Retrieve Passport
08/10/2026
Agreement with a leading U.S. financial services and membership platform establishes a major new consumer distribution channel. BEDMINSTER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC: [...]
SRX Global Commits $2.5 Million to Launch Multi-Strategy Trading Platform in Partnership with 5T Trading, Powered by the EMJX Platform
08/10/2026
New platform to be launched with managers from Millennium Management, Balyasny and Citadel, designed to enable the next generation of proprietary traders under Eric Jackson’s leadership NORTH PALM BEACH, Fla., Oct. 08, [...]
Vaxart Announces Publication of Preclinical Study Demonstrating 100% Protection Against a Lethal Dose of H5N1 Avian Flu in a Ferret Challenge Model
08/10/2026
Second-generation oral mucosal vaccine candidate (VXA-H5-02) induced robust cross-neutralizing antibodies, significantly reduced viral load, and completely protected against lethal clade 2.3.4.4b viral challenge SOUTH [...]
IMUNON to Participate in Upcoming Investor Conferences
08/10/2026
LAWRENCEVILLE, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediated immunotherapies, today announced that Stacy Lindborg, Ph.D., President [...]
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
08/10/2026
SALT LAKE CITY and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine and SOPHiA GENETICS (NASDAQ: SOPH) today announce a [...]
Privia Health to Report Third Quarter 2026 Results on Thursday, November 5
08/10/2026
ARLINGTON, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, [...]
Precision Neuroscience Unveils a New Map of the Human Nervous System
08/10/2026
A uniquely large dataset spanning cortex, brainstem, and spinal cord in 70 patients—released as the Precision system passes its 100th patient implant NEW YORK, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Precision Neuroscience [...]
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
08/10/2026
Continued participation underscores commitment to expanding options for patients referred to fertility centers under the care of reproductive endocrinologists ATLANTA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. ( [...]
Solera Health Launches Cancer Care Network to Connect Members to Digital Cancer Screening, Supportive Care and Treatment Navigation
08/10/2026
Network pairs Iris by OncoHealth® and Fuze Health to support members across their journey, from early detection through care navigation PHOENIX, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Solera Health , the premier digital [...]
Fieldstone Bio Selected for Rio Tinto and Founders Factory Mining Tech Accelerator
08/10/2026
Investment marks Fieldstone's first backing from the mining industry WOBURN, Mass., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Fieldstone Bio , a synthetic biology company building a new class of critical-mineral biosensors, [...]
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
08/10/2026
Medical Director Annie Thurman, MD, FACOG to present adverse event and relative bioavailability data comparing topical Sildenafil Cream with oral sildenafil in healthy male adults SAN DIEGO, Oct. 08, 2026 (GLOBE [...]
Biofrontera Submits Supplemental New Drug Application to FDA to Expand Ameluz® Red Light PDT to Actinic Keratoses on the Full Body
08/10/2026
Submission seeks to extend the Ameluz ® label beyond the face and scalp to treatment fields of up to approximately 240 cm² on the rest of the body, with an adjusted illumination protocol WOBURN, Mass., Oct. 08, 2026 ( [...]
World Spine Day 2026: Small Changes Can Make a Big Difference
08/10/2026
Experience Better Back Health PLANO, Texas, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Dallas Neurosurgical & Spine doctors Jeremy Denning , MD, and Krishna Satyan , MD, are gearing up for World Spine Day, by providing tips [...]
Sienna Announces Third Quarter 2026 Results Release Date and Conference Call
08/10/2026
MARKHAM, Ontario, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2026 third quarter results after market close on Thursday, [...]
HealthTab™ and HeartEye Open New Referral Pathway into Community Pharmacy
08/10/2026
VANCOUVER, British Columbia, Oct. 08, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) is pleased to announce that its wholly owned subsidiary, HealthTab Ltd. (“HealthTab”), has [...]
Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model
08/10/2026
CALGARY, Alberta, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF ), and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug [...]
Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution
08/10/2026
First-Quarter Results Reinforce Tilray’s Progress Converting Global Scale, Disciplined Execution and Category Leadership into Higher Revenue, Expanded Gross Profit and Continued Momentum Record First-Quarter Net Revenue [...]
Gain Therapeutics to Attend the 2026 Maxim Growth Summit
08/10/2026
BETHESDA, Md., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of [...]

Pages